Latest AI and machine learning research in other cancers for healthcare professionals.
OBJECTIVES: Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) weakened the diagnostic ability of traditional elastography ultrasound on liver fibrosis. Combi-elasto ultrasound can simultaneously reflect the information of fibrosis degree and fat accumulation, thus have better potential and generality for liver fibrosis. We ...
Tumor recurrence represents a significant challenge in the field of tumor therapy, severely affecting patients' survival rates and quality of life. Even after standard treatments, many patients still experience tumor recurrence. Traditional radiotherapy, chemotherapy, and targeted therapies can induce tumor cell senescence to suppress tumor growth and dissemination. However, recent studies have sh...
BACKGROUND: Hepatocellular carcinoma (HCC) arises within a hypoxic and immunosuppressive tumor microenvironment (TME), where tumor-associated macropha...
PURPOSE: This study aimed to evaluate the feasibility of employing habitat-based radiomic distributions in ultrasound (US) images to quantitatively ch...
BACKGROUND: Portal vein tumor thrombus is a lethal complication of HCC for which effective biomarkers are urgently needed. METHODS: Through proteomic ...
INTRODUCTION: The search for actionable genetic targets in cancer has evolved substantially over the past decade. Earlier approaches were focused on s...
OBJECTIVE: The aim of this study was to integrate multimodal intratumoral and peritumoral ultrasound radiomic features with clinical data to construct...
OBJECTIVES: This study aimed to develop and validate a CBCT-based automated system for assessing radiographic alveolar bone loss (RBL) to improve the ...
Over the past three decades, adenosine signalling has emerged as a fundamental regulatory system controlling immune responses, tissue homeostasis, met...
Triple-negative breast cancer (TNBC), being one of the most aggressive subtypes of breast malignancies, is characterized by poor prognosis and limited...
Hypoxia, a hallmark of solid tumors, drives malignant progression and represents a major therapeutic challenge. Metabolic reprogramming induced by hyp...
BACKGROUND AND AIMS: Tertiary lymphoid structures (TLS) are associated with heterogeneous outcomes in hepatocellular carcinoma (HCC), but whether thei...
OBJECTIVE: Lateral cervical lymph node metastasis (LLNM) is missed in up to 30% of papillary thyroid carcinoma (PTC) patients pre-operatively, leading...
PURPOSE: Autophagy is increasingly recognized as a promising therapeutic target in prostate cancer (PCa), yet its research landscape has not been syst...
BACKGROUND: Current guidelines recommend pancolonic chromoendoscopy (pCE) over white light endoscopy (WLE) alone for colorectal neoplasia (CRN) detect...
INTRODUCTION: Nasopharyngeal carcinoma (NPC) is rare in Europe, and emerging data suggest poorer outcomes in Caucasian patients compared with Asian po...
Access to high-quality cancer care remains a major challenge across Latin America, particularly for patients with gastrointestinal (GI) malignancies. ...
The heterogeneity within the same AJCC TNM stage of gastric cancer necessitates robust prognostic biomarkers beyond conventional staging. By integrati...
INTRODUCTION: OSTC and TUBA1C drive the malignant progression of lung adenocarcinoma (LUAD) through the modulation of N-glycosylation and the PI3K/AKT...
BACKGROUND: EGFR-mutant lung adenocarcinoma (LUAD) exhibits significant prognostic heterogeneity despite the efficacy of tyrosine kinase inhibitors. T...